Drug Profile
Research programme: infectious diseases vaccines - iBio/Immunological Technology Institute
Alternative Names: Yellow fever vaccine - iBio/Immunological Technology InstituteLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Immunobiological Technology Institute; Oswaldo Cruz Foundation
- Class Recombinant proteins; Vaccines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Yellow fever
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for preclinical development in Yellow-fever in Brazil (Parenteral)
- 25 Jul 2016 Preclinical development is ongoing in Brazil (iBio pipeline, July 2016)
- 17 Jun 2014 iBio, Bio-Manguinhos/Fiocruz and Fraunhofer USA Centre for Molecular Biotechnology expand their collaboration agreement for development of recombinant vaccines for Yellow fever